List view / Grid view
8 April 2016 | By Victoria White, Digital Content Producer
A new study is the first to show that tumours can become resistant to drugs over time by learning to steal normal blood vessels from surrounding tissue...
8 April 2016 | By Victoria White
Nanoparticles designed to block a cell-surface molecule that plays a key role in inflammation could be a safe treatment for inflammatory bowel disease...
7 April 2016 | By Victoria White, Digital Content Producer
MRC Technology has appointed Dr Les Hughes and Dr Mike Romanos to the board of trustees, effective 1 March 2016...
7 April 2016 | By Victoria White, Digital Content Producer
Allergan is to license exclusive global rights to a broad portfolio of novel subtype-selective muscarinic receptor agonists in development by Heptares...
6 April 2016 | By Victoria White
The parties created IPS-MRCT Joint Centre for Therapeutic Antibodies in order to combine their expertise in research and development...
6 April 2016 | By Victoria White
The decision was driven by the actions announced by the US Department of Treasury to reform inversion tax rules, which the companies concluded qualified as an “Adverse Tax Law Change”. Market rumour suggests that Pfizer will now target Shire or AstraZeneca and shares in both companies went up with the…
6 April 2016 | By Victoria White
Scientists have described the first-ever immature antibody found in a powerful class of immune molecules effective against HIV. TSRI biologist Jiang Zhu called the antibody a “teenager” and said it gives scientists a unique view of the steps needed to prompt the immune system to effectively target HIV...
6 April 2016 | By Victoria White
Laura Bohn, principal investigator of the project, will focus on the kappa opioid receptor, which helps regulate the release of dopamine...
5 April 2016 | By Victoria White
The mouse model of Zika mimics aspects of the infection in humans, with high levels of the virus seen in the mouse brain and spinal cord...
5 April 2016 | By Victoria White
A research team investigated the impact of compounds related to cholesterol on the TB causing bacterium Mycobacterium tuberculosis...
5 April 2016 | By Victoria White
Research will include studies into how combinations of adjuvants interact with the immune system, and how synergies between adjuvants can be optimised...
1 April 2016 | By Victoria White
Astellas and AIST aim to discover new drugs using genome editing technology and a high throughput activity assay for Trypanosoma cruzi...
1 April 2016 | By Victoria White
Researchers hope to use the technology to develop an ovary bioprosthesis that could be implanted in women to restore fertility...
1 April 2016 | By Victoria White
Researchers have determined the structure of the Zika virus, revealing insights critical to the development of effective antiviral treatments and vaccines...
31 March 2016 | By Victoria White
Commense has advanced its development platform, named its founding scientists and advisors, and executed an exclusive license in the microbiome field...
